Celgene price target raised to $87 from $79 at Citigroup Citigroup raised its price target for Celgene citing the company's pipeline catalysts and said it likes the risk/reward at current levels. The firm keeps a Buy rating on the stock.
News For CELG From The Last 14 Days
Check below for free stories on CELG the last two weeks.